AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 229 filers reported holding AMICUS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $413,926 | -48.2% | 34,040 | -46.5% | 0.05% | -63.6% |
| Q2 2023 | $798,540 | +591.1% | 63,578 | +510.2% | 0.13% | +450.0% |
| Q1 2023 | $115,547 | -58.0% | 10,419 | -60.4% | 0.02% | -56.4% |
| Q3 2022 | $275,000 | +18.0% | 26,303 | +6.7% | 0.06% | +77.4% |
| Q1 2022 | $233,000 | -27.9% | 24,651 | -11.8% | 0.03% | -46.6% |
| Q4 2021 | $323,000 | +115.3% | 27,934 | +77.9% | 0.06% | +314.3% |
| Q3 2021 | $150,000 | -71.3% | 15,700 | -30.5% | 0.01% | -88.3% |
| Q1 2021 | $522,000 | 0.0% | 22,603 | 0.0% | 0.12% | +0.8% |
| Q4 2020 | $522,000 | +155.9% | 22,603 | +56.4% | 0.12% | +170.5% |
| Q3 2020 | $204,000 | +25.9% | 14,454 | +34.4% | 0.04% | -63.0% |
| Q2 2020 | $162,000 | -83.9% | 10,754 | -83.9% | 0.12% | +43.4% |
| Q1 2018 | $1,004,000 | -48.4% | 66,755 | -50.6% | 0.08% | -58.1% |
| Q4 2017 | $1,944,000 | +11.4% | 135,100 | +16.8% | 0.20% | -7.0% |
| Q3 2017 | $1,745,000 | +21712.5% | 115,700 | +14362.5% | 0.21% | +21200.0% |
| Q2 2017 | $8,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,114,043 | $116,817,000 | 7.46% |
| Parametrica Management Ltd | 597,279 | $6,899,000 | 6.86% |
| Redmile Group, LLC | 22,716,086 | $262,371,000 | 5.96% |
| Perceptive Advisors | 53,118,886 | $613,524,000 | 4.73% |
| Asymmetry Capital Management, L.P. | 716,709 | $8,278,000 | 4.39% |
| CM Management, LLC | 450,000 | $5,198,000 | 3.93% |
| Avoro Capital Advisors LLC | 18,500,000 | $213,675,000 | 3.64% |
| Kynam Capital Management, LP | 573,699 | $6,626,000 | 3.54% |
| SECTORAL ASSET MANAGEMENT INC | 1,242,882 | $14,355,000 | 2.16% |
| Ghost Tree Capital, LLC | 500,000 | $5,775,000 | 2.07% |